News on Medial

Exclusive: XYXX raises fresh funds led by Niveshaay Sambhav Fund

EntrackrEntrackr · 4m ago
Exclusive: XYXX raises fresh funds led by Niveshaay Sambhav Fund
Medial

Men-focused premium innerwear and lifestyle brand XYXX is raising Rs 30 crore ($3.6 million) in a funding round led by Niveshaay Sambhav Fund, with participation from Anicut Capital, DSG Consumer Fund, and Sauce Continuity Fund. The board at XYXX has passed a special resolution to issue 1,81,818 Series B2 CCPS at an issue price of Rs 1,650 each to raise the aforementioned sum, its regulatory filing accessed from the Registrar of Companies shows. Niveshaay Sambhav Fund will invest Rs 9.93 crore, while Anicut Capital, Sauce Continuity Fund, and DSG Consumer Partners will contribute Rs 7.95 crore, Rs 4.96 crore, and Rs 1.99 crore, respectively. The remaining amount will be invested by Singularity Growth, Selenium Trust, Veena Merchants, and Arun Venkatachalam HUF. XYXX will use these proceeds to meet the capex and working capital requirements for the ongoing operations. According to Entrackr's estimates, it will be valued at around Rs 820 crore post-allotment. XYXX is a lifestyle brand specializing in underwear, loungewear, and athleisure, crafted from premium fabrics. The company claims to have built a network of over 18,000 retailers across 50 cities. Besides its own website, XYXX retails on various marketplaces and claims to be among the top three innerwear brands. In FY23, the company launched its first store in central Mumbai and now plans to expand with new outlets in Indore and Bangalore. XYXX has raised Rs 250 crore to date, including Rs 110 crore led by Amazon Smbhav Venture Fund in May 2023. According to the startup data intelligence platform TheKredible, before this round, Sauce.vc was the largest external stakeholder, followed by DSG Consumer Fund and Amazon Smbhav Venture Fund. XYXX recorded a 25% year-on-year revenue growth, rising from Rs 105 crore in FY23 to Rs 131 crore in FY24. Simultaneously, the company trimmed its losses by 22.2% to Rs 35 crore in FY24.

Related News

Exclusive: DaMENSCH raises fresh capital from existing investors at flat valuation

EntrackrEntrackr · 1y ago
Exclusive: DaMENSCH raises fresh capital from existing investors at flat valuation
Medial

D2C men’s lifestyle brand DaMENSCH has raised Rs 21.62 crore (approximately $2.5 million) in its extended Series B round from existing investors. The fresh investment, which came after a gap of two years, appears to be a bridge round for the Bengaluru-based company. The board at DaMENSCH has passed a special resolution to issue 1,017 shares at an issue price of Rs 2,12,515 each to raise Rs 21.6 crore, its regulatory filing accessed from the Registrar of Companies shows. Existing investors including Matrix Partners, Saama Capital, Whiteboard Capital, and A91 Emerging Fund also participated during the round. The bridge round has flown in at a flat valuation. As per TheKredible estimates, it has been valued at around $70-75 million (post-money). DaMENSCH has raised over $25 million to date including its $16.6 million Series B round led by A91 Partners in February 2022. According to the startup data intelligence platform TheKredible, A91 Partners is the largest external stakeholder followed by Matrix and Saama Capital. Started in 2018 by Anurag Saboo and Gaurav Pushkar, DaMENSCH offers a range of innerwear and casual wear. It leverages its own website and marketplaces such as Amazon, Flipkart, and Myntra for distribution. While the company is yet to file its financial statements for FY24, DaMENSCH’s revenue grew 22.7% year-on-year to Rs 77.57 crore in FY23. Unlike its scale, the firm’s losses surged twofold to Rs 62.34 crore in the fiscal year ending March 2023. DaMENSCH directly competes with Bummer which secured Rs 9.25 crore from Gruhas Collective Consumer Fund in March. XYXX seems to be the most funded player in the space as it raised over $36 million to date including $13.5 million from Amazon Sambhav Fund in May last year.

Exclusive: Bare Anatomy parent Innovist kicks off Series B round

EntrackrEntrackr · 3m ago
Exclusive: Bare Anatomy parent Innovist kicks off Series B round
Medial

Innovist, the parent company of Bare Anatomy, Chemist at Play, and Sunscoop, is raising Rs 49.25 crore (approximately $5.7 million) in its Series B round. This marks the first round of investment for the Gurugram-based company in 2025. The board at Innovist has passed a special resolution to issue 72,223 Series B compulsory convertible preference shares at an issue price of Rs 6,819 each, raising Rs 49.25 crore, according to its regulatory filing accessed from the Registrar of Companies (RoC). IVen Amplifi Fund (managed by ICICI Ventures Fund) will lead the round with Rs 19.47 crore, while Mirabilis Investment Trust will contribute Rs 10.1 crore. Sauce.VC and Niveshaay Sambhav Fund will also participate, investing Rs 8.75 crore and Rs 10 crore, respectively. The fresh proceeds will be utilized for recruitment, operations, sales, marketing, and other general corporate purposes, as decided by the board. According to Entrackr estimates, the company will be valued at approximately $140 million post-allotment. This capital infusion appears to be part of a larger funding round, with the potential for additional investments that could further impact its valuation. Founded in 2018 by Rohit Chawla, Sifat Khurana, and Vimal Bhola, Innovist—formerly known as Onesto Labs—offers personal care products. It currently operates three brands: Bare Anatomy, Chemist at Play, and Sunscoop. Innovist has raised over $16 million to date, including a $7 million Series A round led by the Amazon Smbhav Venture Fund. According to the startup data intelligence platform TheKredible, prior to this round, Sauce.VC was the largest external stakeholder, followed by 72 Ventures, Accel India, and the Amazon Smbhav Fund. The company has not yet filed its annual statements for the previous fiscal year (FY24). In FY23, it reported operational revenue of Rs 36.53 crore, while its losses amounted to Rs 16.87 crore during the same period.

Exclusive: Anant Goel’s Handpickd raises fresh funds

EntrackrEntrackr · 1m ago
Exclusive: Anant Goel’s Handpickd raises fresh funds
Medial

Exclusive: Anant Goel’s Handpickd raises fresh funds Fresh produce startup Handpickd (formerly Sorted) is raising Rs 21.7 crore in an extended seed round led by Nitin Gupta and Genesia Ventures, with participation from BEENEXT and others. Fresh farm produce and supply chain startup Handpickd (previously Sorted) is raising Rs 21.7 crore in an extended seed round led by Nitin Gupta and Genesia Ventures with the participation of BEENEXT, Stargazer Ventures, Eximius Ventures, Sunrise Sunset Family Trust, and others. The Handpickd’s board passed a resolution to approve the issue of 10,547 Series Seed B CCPS at an issue price of Rs 20,566 to raise Rs 21.7 crore or around $2.5 million, according to recent filings accessed from March 2025 from the Registrar of Companies (RoC) shows. Nitin Gupta, Partner at GG Enterprises and Genesia Ventures, led the round with an investment of Rs 6.48 crore and Rs 6 crore, respectively, followed by existing investor BEENEXT, which is contributing Rs 2.16 crore. Sunrise Sunset Family Office will invest Rs 2 crore, while the remaining amount will be covered by Infinyte Club Angel Fund and Eximius Ventures, Stargazer Ventures and Ankit Agarwal. As per filings, the company has already received around Rs 10.16 crore, with the remaining amount expected to follow shortly. The Blume Venture-backed company will be valued at around Rs 300 crore or $35 million, according to Entrackr’s estimates. Founded by Anant Goel along with Nitin Gupta and Sahil Madan, Handpickd operates on a B2B2C model, delivering fresh fruits and vegetables through a tech-enabled supply chain. The company sources produce directly from local farmers and vendors, leveraging a network of micro-entrepreneurs for efficient last-mile delivery. According to startup data intelligence platform TheKredible, Handpickd has raised around $9 million from investors including BEENEXT, Blume Ventures, Kunal Bahl, Rohit Kumar Bansal. The company recorded over 2.3X year-on-year growth in operating revenue, rising to Rs 17.5 crore in FY24 from Rs 7.4 crore in FY23. Its losses remained flat at Rs 2.1 crore during the fiscal year ending March 2024. Handpickd competes with other farm-to-fork funded startups including Otipy ($49 million), Fraazo ($61 million), Deep Rooted ($20 million) which shut their operations. Handpickd also competes with Kareena Kapoor-backed startup Pluckk which is set to raise $10 million.

Exclusive: Accel-backed biotech startup Mynvax raises fresh funds

EntrackrEntrackr · 1y ago
Exclusive: Accel-backed biotech startup Mynvax raises fresh funds
Medial

Biotech startup Mynvax has raised Rs 21.63 crore ($2.6 million approximately) in an extended Series A round led by Inviga Healthcare Fund. This is a fresh round of investment for the Bengaluru-based company after a hiatus of almost three years. The board at Mynvax has passed a special resolution to issue 5,127 Series A1 CCPS at an issue price of Rs 42,182 per share to raise Rs 21.63 crore, its regulatory filing accessed from RoC shows. Inviga Healthcare Fund invested Rs 15 crore while Legacy Assets LLP pumped in Rs 2 crore. The rest of the capital came from 27 other investors in small proportions. As per TheKredible’s estimates, Mynvax is valued at around Rs 257 crore or $31 million post-money. Mynvax has raised around $9-10 million to date including a $4.2 million Series A round led by Accel and with the participation of Lets Venture, 1Cword, Kotak Investments, and others. Following the fresh process, Accel remains the largest external stakeholder with 15.63% shares followed by Kotak Investment and Invigia. Its co-founders Raghavan Varadarjan and Gautam Nadig cumulatively command a 24.7% stake in the company. Head to TheKredible for the complete shareholding pattern. Founded in 2017, Mynvax develops novel, engineered protein subunit vaccines using their technology for protein stabilization. The company made influenza vaccine and thermo-tolerant, efficacious vaccines for protection against SARS-CoV-2 and its evolving variants in recent years. Mynvax’s revenue from operations grew 89% to Rs 10.94 crore during the fiscal year ending March 2023 while its losses stood at Rs 6.43 crore in the same period. The company is yet to file its financial statements for the last fiscal year (FY24).

Exclusive: Proptech startup HouseEazy raises $4 Mn in Series A

EntrackrEntrackr · 10m ago
Exclusive: Proptech startup HouseEazy raises $4 Mn in Series A
Medial

HouseEazy, an online marketplace for pre-owned homes, has raised Rs 33.5 crore (around $4 million) in Series A led by Chiratae Ventures Fund with participation from Veena Jindal, Antler Innovation Fund, and IA Growth Opportunities Fund. The board at HouseEazy has issued a total of 3,915 shares at a face value of Rs 10 and premium of Rs 85,666 on preferential basis and by way of private placement, the company’s regulatory filings with Registrar of Companies show. Chiratae Ventures has invested Rs 29.62 crore, whereas Antler Innovation Fund invested Rs 2.86 crore. IA Growth Opportunities Fund and Veena Jindal invested Rs 76.25 lakh and Rs 29 lakh respectively. As per startup data intelligence platform TheKredible, HouseEazy has reached a valuation of Rs 156 crore post money (over $18 million). The company may raise more funds in this round and the valuation will vary accordingly. In December 2023, HouseEazy raised $1 million in a seed round led by Antler and picked up $370,000 in pre seed funding in June 2022. Founded in 2021 by Tarun Sainani and Deepak Bhatia, HouseEazy is building a full-stack, data driven technology platform to provide the best prices and instant liquidity to sellers and title-checked, refurbished, ready-to-move-in homes to buyers. The Noida-based company says that it uses a proprietary machine-learning algorithm with over 1.25 million data points to provide real-time price offers, eliminating the need for multiple meetings & negotiations for sellers. In December, HouseEazy claimed that it reached an ARR of Rs 250 crore (GMV) while maintaining profitability. The firm expects to hit Rs 1,000 crore ARR by March 2025 from the NCR market alone. For the fiscal year ending March 2023 (FY23), HouseEazy registered Rs 2.78 crore in operating revenue with Rs 44 lakh in loss.

Download the medial app to read full posts, comements and news.